4//SEC Filing
LIPOSCIENCE INC 4
Accession 0001127602-14-002383
CIK 0001168197operating
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:49 PM ET
Size
10.3 KB
Accession
0001127602-14-002383
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Martindale Lucy G.
EVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2014-01-17$2.50/sh+7,275$18,188→ 87,881 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-01-17−8,730→ 0 totalExercise: $2.50Exp: 2014-02-04→ Common Stock (8,730 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2014-01-17−7,275→ 0 totalExercise: $2.50Exp: 2014-02-14→ Common Stock (7,275 underlying) - Exercise/Conversion
Common Stock
2014-01-17$2.50/sh+8,730$21,825→ 80,606 total
Footnotes (2)
- [F1]The option is fully vested and immediately exercisable. 50% of the shares underlying the option were vested upon issuance on February 4, 2004, with the remainder vesting in 24 equal monthly installments thereafter.
- [F2]The option is fully vested and immediately exercisable. 37.5% of the shares underlying the option were vested upon issuance on February 4, 2004, with the remainder vesting in 30 equal monthly installments thereafter.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168197
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:49 PM ET
- Size
- 10.3 KB